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ABSTRACT
Objective: Assessment of delirium is performed with a variety of instruments, making
comparisons between studies difficult. A conversion rule between commonly used instruments
would aid such comparisons. The present study aimed to compare the revised Delirium Rating
Scale (DRS–R98) and Memorial Delirium Assessment Scale (MDAS) in a palliative care
population and derive conversion rules between the two scales.
Method: Both instruments were employed to assess 77 consecutive patients with DSM–IV
delirium, and the measures were repeated at three-day intervals. Conversion rules were derived
from the data at initial assessment and tested on subsequent data.
Results: There was substantial overall agreement between the two scales [concordance
correlation coefficient (CCC) ¼ 0.70 (CI95 ¼ 0.60–0.78)] and between most common items
(weighted k ranging from 0.63 to 0.86). Although the two scales overlap considerably, there were
some subtle differences with only modest agreement between the attention (weighted k ¼ 0.42)
and thought process (weighted k ¼ 0.61) items. The conversion rule from total MDAS score to
DRS–R98 severity scores demonstrated an almost perfect level of agreement (r ¼ 0.86, CCC ¼
0.86; CI95 ¼ 0.79–0.91), similar to the conversion rule from DRS–R98 to MDAS.
Significance of results: Overall, the derived conversion rules demonstrated promising
accuracy in this palliative care population, but further testing in other populations is certainly
needed.
KEYWORDS: Delirium, Delirium scales, Phenomenology, Assessment, DRS–R98, MDAS,
Equation method
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INTRODUCTION
Delirium is a complex neuropsychiatric syndrome
that is common across healthcare settings and associ-
ated with a variety of adverse outcomes (Breitbart &
Alici, 2012; Ryan et al., 2013). Although historically
understudied, the past decade has witnessed increas-
ing interest in the detection and treatment of this
important condition (Meagher et al., 2013). The phe-
nomenological assessment of delirium, including
its severity, has become increasingly important, as
studies exploring a variety of pharmacological and
nonpharmacological treatments have increased.
In a review of prospective studies of the treatment
of delirium, Meagher et al. (2013) found that, though
the original DRS was the most commonly used in-
strument overall, for recent studies the Revised De-
lirium Rating Scale (DRS–R98) and Memorial
Delirium Assessment Scale (MDAS) were the instru-
ments most commonly utilized to measure treatment
response. Although evidence indicates a high corre-
lation between the MDAS and the original DRS
(r ¼ 0.88) (Breitbart et al., 1997), direct comparisons
of the MDAS and DRS–R98 scales are lacking. Un-
like the confusion assessment method (CAM), both
measure the severity of a broad range of symptoms.
Additionally, because some studies employ the
MDAS and others the DRS–R98, having a conver-
sion system to apply to scores could be useful to allow
for more direct comparison of study results, including
the magnitude of treatment effects. In clinical set-
tings, the MDAS might be used by less well-trained
clinical staff due to its ease of use and simpler format
while specialists might use the DRS–R98. An accu-
rate and validated conversion algorithm could allow
more continuity over time for patients rated with
both scales. Although these scales were originally de-
signed for broad usage, they have been validated and
often used in particular settings; for instance, the
MDAS was initially derived and validated for hospi-
talized patients with cancer and AIDS but often has
been used for palliative care patients. The DRS–R98
was initially validated for inpatients with medical/
surgical conditions and psychiatric patients but later
validated in nursing homes, for patients with stroke,
and in orthopedic rehabilitation units, and is often
utilized in geriatrics wards and for consultation-
liaison psychiatry (Adamis et al., 2010). As such, a
comparison of their performance in a single popu-
lation (e.g., palliative care) could explore their level
of agreement within a particular clinical setting.
Therefore, the aims of our study were as follows:
1. to compare DRS–R98 and MDAS agreement in
assessment of delirium in a population of 77 pal-
liative care patients with delirium,
2. to investigate the level of agreement between
the scales considering separately common and
unique items,
3. to derive a conversion formula between the two
scales and test it by using the second assess-
ment of 76/77 patients.
METHODS
Subjects and Design
This observational longitudinal study of delirium
symptoms and cognitive performance evaluated
77 consecutive patients with DSM–IV delirium.
Patients were referred to the psychiatric consul-
tation-liaison service’s delirium research team at a
palliative care inpatient service at Milford Care Hos-
pice. All patients were routinely assessed daily for
altered mental states, and where any indication of
possible delirium was evident also formally screened
with the confusion assessment method algorithm
(CAM) by a medical team trained in its use to sup-
plement routine case finding for delirium. Patients
with CAM-positive status or other altered mental
states were referred to the psychiatry team for further
evaluation and expert diagnosis of delirium using
DSM–IV criteria. In order to optimize the real-world
nature of the study, both incident and prevalent cases
of delirium were included. Patients were not included
if they were imminently dying or where circumstan-
ces were too difficult to allow assessment (as per the
opinion of the treating medical team).
Procedures
The current report derives from data that formed
part of a previous report of longitudinal symptom pat-
terns over the course of an episode of delirium that in-
volved biweekly assessments (Meagher et al., 2011).
For the purpose of the present study, we investigated
the relationship between the MDAS and DRS–R98 at
first assessment (n ¼ 77), and then employed MDAS
and DRS–R98 data from the second assessment
(three days later) to test a conversion formula derived
from analyses of the first assessment data.
Assessments were conducted by research psychia-
trists trained in the use of the DRS–R98 and MDAS
(DM or ML), and, to further enhance reliability, diffi-
cult ratings were discussed and rated by consensus
between both raters.
Scales
Revised Delirium Rating Scale (DRS–R98)
The DRS–R98 is the instrument most widely em-
ployed to measure symptom severity in delirium
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and is useful as both a diagnostic and a severity as-
sessment tool (Trzepacz et al., 2010). It is a 16-item
clinician-rated scale with 13 severity items and 3 di-
agnostic items (temporal onset of symptoms, fluctu-
ation of symptoms, physical disorder) and is a valid
measure of delirium severity over a broad range of
symptoms. The 13-item severity section can be scored
separately from the 3-item diagnostic section; their
sum constitutes the total scale score. The severity
of individual items is rated from 0 to 3 points. Thus,
DRS–R98 severity scale scores range from 0 to 39,
with higher scores indicating more severe delirium
and a cutoff score above 15 consistent with a diagno-
sis of delirium. Total scale scores range from 0 to 46,
with a score greater than 18 consistent with a delir-
ium diagnosis. All items are anchored by text de-
scriptions of phenomenology as guides for rating
along a continuum from normal to severely impaired.
The instrument can be employed to rate symptoms
over variable periods from hours to weeks, and for
the purposes of our study was applied twice weekly
to encompass the previous 3–4 day period (i.e., since
last assessment). It has high interrater reliability,
validity, sensitivity, and specificity in distinguishing
delirium from mixed neuropsychiatric populations,
including dementia, depression, and schizophrenia
(Trzepacz et al., 2001). Completion time is 15–20
minutes.
Memorial Delirium Assessment Scale (MDAS)
The Memorial Delirium Assessment Scale (MDAS) is
a 10-item, clinician-rated scale (possible range 0–30)
designed to quantify both the severity of delirium and
the presence/absence of delirium when cutoff points
are applied. Each item is rated on a Likert-type scale
(0–3: absent–mild–moderate–severe). Items inclu-
ded in the MDAS reflect the diagnostic criteria for de-
lirium in the DSM–IV, as well as symptoms of
delirium from earlier or alternative classification sys-
tems (e.g., DSM–III, DSM–III–R, ICD-9). It consists
of a combination of cognitive and neuropsychiatric
items and is suited for both quantification of delirium
severity and screening or diagnosis, although, re-
garding the latter, a range of possible diagnostic cut-
off scores has been suggested varying from 7 to 13
across cancer, palliative care, elderly orthopedic,
and cardiac surgery populations (Breitbart et al.,
1997; Marcantonio et al., 2002; Kazmierski et al.,
2008). Completion time is approximately 10 minutes.
For the purposes of our study, DRS–R98 ratings
were conducted prior to the MDAS to minimize cross-
contamination of assessments. Attention (item 10) on
the DRS–R98 was assessed according to perform-
ance on the months-backward test, with scores of 0
(no problems), 1 (able to recite the months at least
as far as July but with some difficulty), 2 (failure to
reach at least July), and 3 (difficulties with the basic
sequencing of the test and/or unable to engage coher-
ently with the test). For MDAS attention (item 5), a
reduced ability to maintain and shift attention was
assessed according to general behavior and perform-
ance during the assessment.
Preexisting Cognitive Impairment/Dementia
Dementia due to various causes was defined as the
presence of persistent cognitive impairment for at
least six months prior to assessment and per DSM–
IV criteria based on all available information at the
time of initial assessment, including clinical case
notes and collateral history from family and/or carers.
Ethics
The procedures and rationale for the study were ex-
plained to all patients, but because the majority
had an index episode of delirium at entry, it was re-
cognized that most would not be capable of giving in-
formed consent. Because of the noninvasive nature of
the study, the Limerick Regional Ethics Committee
approved verbal patient assent augmented by proxy
consent from next of kin (where possible) or a respon-
sible caregiver. This is in accordance with best practi-
ces as outlined in the Helsinki Guidelines for Medical
Research Involving Human Subjects (World Medical
Association, 2014).
Statistical Analyses
Statistical analyses were conducted using the PAWS
(SPSS v. 19) and the [R]Psych packages (Revelle
(2013). Overall agreement between the two scales
was assessed using Pearson’s product-moment corre-
lation coefficient. However, this estimation has been
criticized by Bland and Altman (1986) as misleading,
so the concordance correlation coefficient (CCC) was
also calculated. The CCC was introduced by Lin
(1989) and measures agreement by assessing how
well the relationship between measurements is rep-
resented by a line through the origin at an angle of
458 (as would be generated if the two measurements
generated identical results). The two scales have se-
ven common items that measure symptoms of delir-
ium but in somewhat different ways (see Table 1).
Since neither of these scales can be considered a
gold standard, we examined the agreement of com-
mon items. Agreement of these items was assessed
using polychoric correlations (Olsson, 1979). For
both scales, each item is rated from 0 to 3 in ordinal
terms, but with an assumed continuous underlying
latent variable (severity), which is measured by the
four points. Similarly, for reasons of comparison,
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we calculated Cohen’s kappa coefficient, which is a
more conservative measure of agreement. Given
that in each item there are four categories, we utilized
squared weighted kappa (where disagreements are
weighted according to their squared distance from
perfect agreement) (Cohen, 1968; Fleiss et al., 1969).
The concordance (concurred validity) of each of the
seven common items was also estimated. Concor-
dance reflects the interchangeability of two scales,
where if two items are concordant they will produce
the same ordering of individuals. Goodman–Krus-
kal’s gamma (g) is a measure based on the difference
between the numbers of concordant and discordant
pairs adjusted for ties on the marginal distribution
(Goodman & Kruskal, 1963). The value of g can
vary between 21 and 1, where a value of 1 indicates
perfect concordance and 0 a total absence of concor-
dance Svensson (2000).
To derive a rule for conversion of MDAS to DRS–
R98 (and vice versa), we generated an equation to
link the two scales. Conversions were extracted from
the first assessment and then tested in the second
data assessment. The conversion rule is derived ac-
cording to the following equation (Kolen & Tong, 2005):




where m(X ) is the mean score of the referred variable
(in this case, MDAS), s(X ) the standard deviation of
MDAS scores, m(Y ) the mean DRS–R98 score, s(Y )
the standard deviation of DRS–R98 scores, and lg
the linear equating function.
In doing this, we have made the following assump-
tions: (1) both scales measure the same latent con-
struct (in this case, delirium); (2) the two scales are
not free from error, but the errors are small (both
scales must have high reliability); and (3) the ratings
have been conducted by experts and the conversion
rule will apply again in measurements that have
been done by experts. Although both scales are con-
tinuous, they are discretized continuous, meaning
that the score of person A on the DRS–R98 (or
MDAS) will be 11 and never 11.2, so that the deliv-
ered MDAS score needs to be converted to the nearest
integer (and vice versa). However, this may not be
necessary for statistical use and calculations.
RESULTS
Descriptive Statistics of the Studied Sample
Consecutive patients with DSM–IV delirium (n ¼
77) were assessed with both scales (MDAS and
DRS–R98). The mean age was 70.1+11.1 (range
36–90 years). Some 40 participants (52%) were
male, and 21 (27%) had a history of longstanding cog-
nitive impairment/dementia. At first assessment,
the mean MDAS score was 13.3+5.1 (range 3–26),
and the mean DRS–R98 severity scale score was
16.7+6.1 (range 5–36).
Overall Agreement of the Two Scales
The Pearson’s product-moment correlation coefficient
for the MDAS and DRS–R98 was 0.84 ( p , 0.001).
Figure 1 depicts a scatterplot including a fitted linear
line with a 95% confidence interval (CI95). The CCC
was 0.70 (95%CI95 ¼ 0.60–0.78), indicating substan-
tial agreement between the two scales.
Further, we compared the agreement between the
two scales separately in those with dementia (n ¼ 21)
and in those without cognitive problems (n ¼ 56).
Table 1. Comparison of items from the DRS–R98 and MDAS
DRS–R98 Severity Scale MDAS
Item 1: Sleep–wake cycle disturbance Item 10: Sleep–wake cycle disturbance
Item 2: Perceptual disturbances and hallucinations Item 7: Perceptual disturbance
Item 3: Delusions Item 8: Delusions
Item 4: Lability of affect No corresponding measure
Item 5: Language No corresponding measure
Item 6: Thought process abnormalities Item 6: Disorganized thinking
Item 7: Motor agitation
Item 8: Motor retardation
Item 9: Decreased or increased psychomotor activity
Item 9: Orientation Item 2: Disorientation
Item 10: Attention
(observation at interview or specific
testing—e.g., digit span)
Item 4: Impaired digit span (digit-span test)
Item 5: Reduced ability to maintain and shift attention
(observed at interview)
Item 11: Short-term memory Item 3: Short-term memory impairment
Item 12: Long-term memory No corresponding measure
Item 13: Visuospatial ability No corresponding measure
No corresponding measure Item 1: Reduced level of consciousness
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In those with dementia (r¼ 0.88) the CCC was 0.65
(CI95¼ 0.44–0.80). Thus, the agreement remained
substantial though the CIs were wider, which reflects
the relatively smaller sample size. For those without
dementia, the agreement between the scales was sub-
stantial,with r ¼ 0.84,CCC ¼ 0.71 (CI95¼ 0.59–0.81).
Agreement and Concordance Between
Common DRS–R98 and MDAS Items
The agreement between items (polychoric correlation,
weighted k) and their concordance (g) are presented in
Table 2. Also, the asymptotic standard error (ASE) is
given in the table as a measure of precision. As can
be seen from Table 2, agreement between items
was high, with the exception of those that measure
disorganized thinking and attention, where agree-
ment was somewhat lower but still fair, and in all
cases highly statistically significant (p, 0.001).
Conversion Rules
Conversion Rule from Total MDAS Score to
DRS–R98 Severity Scores
After estimation of means and SD and calculations
according to the above-reported equation, the follow-
ing conversion rule emerged:
DRSR98 severity score ¼ (1:184MDAS score)þ 0:948
Using this rule, we converted total MDAS scores to
DRS–R98 severity scores and then tested these
against the actual DRS–R98 severity scores in the
second wave of assessments. At second assessment,
76 subjects had ratings with both scales bereft of
missing values. The actual DRS–R98 severity scores
had these characteristics: mean ¼ 16.3+6.7, SE of
the mean ¼ 0.77, variance ¼ 44.8, range 4–33. For
the DRS–R98 severity scores converted from
MDAS using the formula: mean ¼ 16.4+7.0, SE of
the mean ¼ 0.80, variance ¼ 49.1, range 1–35.
Thus, agreement between the two scales was very
high and without any significant differences between
the original rated DRS–R98 and the derived version:
r ¼ 0.86, CCC ¼ 0.86 (CI95 ¼ 0.79–0.91), indicating
an almost perfect level of agreement. Therefore, we
concluded that the conversion rule is effective.
Conversion Rule from DRS–R98 to MDAS
Using the same approach as above, a conversion rule
from DRS–R98 to MDAS was generated (the inverse
function of the equation above):
Total MDAS score ¼ (0:845DRS R98 severity score)
 0:808:
Similarly, the DRS–R98-derived MDAS from the
second assessment wave was compared with the ac-
tual MDAS scores. The descriptive statistics for the
actual MDAS scale (n ¼ 76) were: mean ¼ 13.1+
5.9, SE¼ 0.68, variance ¼ 34.9, range 0–30; and
Fig. 1. Linear relationship between MDAS and DRS–R98 and the
95% confidence interval.





Kappa (k) Gamma (g) ASE p Value
Sleep–wake disturbance 0.97 0.86 0.98 0.018 ,0.001
Perceptual disturbances 0.93 0.63 0.95 0.028 ,0.001
Delusions 0.97 0.83 0.96 0.020 ,0.001
Disorganized thinking 0.70 0.61 0.75 0.080 ,0.001
Orientation 0.94 0.66 0.96 0.027 ,0.001
Attention vs. digit span (item 4 MDAS) 0.51 0.42 0.55 0.12 ,0.001
Attention (item 10 vs. item 5) 0.65 0.47 0.66 0.098 ,0.001
Short-term memory 0.93 0.81 0.95 0.033 ,0.001
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the statistics for the derived MDAS scores: mean ¼
12.9+5.6, SE ¼ 0.65, variance ¼ 31.99, range 3–27.
Again, there were no significant differences between
the statistics of the actual MDAS and the DRS–R98-
derived version. Estimations for agreement of the
MDAS and converted MDAS were as follows: r ¼
0.86, CCC ¼ 0.86 (CI95 ¼ 0.79–0.91). Thus, the
agreement was very high, indicating that the conver-
sion rule from DRS–R98 to MDAS also worked well.
DISCUSSION
A variety of scales for delirium screening, diagnosis,
and severity exist, of which a small number are con-
sidered validated and sufficiently robust for use in
clinical and research settings (Adamis et al., 2010).
Consensus on which is the best scale is lacking and
may vary according to the setting in which they are
employed (Adamis et al., 2010). The availability
and use of a variety of scales in delirium research
complicates efforts to directly compare studies. In
the case of drug treatment studies, for example, six
different scales have been employed to assess pri-
mary outcome, of which the MDAS and DRS–R98
are the most commonly applied in recent studies
(Meagher et al., 2013). In our study, we generated
and tested a rule for convenient and rapid conversion
between DRS–R98 and MDAS scores that applies to
patients both with and without comorbid dementia.
We demonstrated a high correlation between the
overall severity scores of the MDAS and DRS–R98 in
a population of palliative care patients. Agreement be-
tween overall scores in cognitively impaired and cogni-
tively intact subgroups was also substantial. There are
a number of differences between the two scales both in
terms of the individual symptoms included and assess-
ment methods. The eight common items showed high
levels of agreement when assessed individually; how-
ever, two items had somewhat lower levels of agree-
ment. First, thought process abnormalities/
disorganized thinking had a modest level of agree-
ment. The criteria for scoring these two items differ
in that the MDAS allows a general observation of de-
gree of disorganized thinking and how this impacts
on the interview, whereas the DRS–R98 more specifi-
cally assesses the character of abnormalities in think-
ing. Similarly, for assessment of attention, the DRS–
R98 combines the interviewer’s observations of per-
formance on the months of the year backward (Trze-
pacz et al., 2010), while the MDAS includes two
items—the interviewer’s assessment and observation
of the patient’s behavior during the interview—and a
separate item that specifically uses performance on
the digit-span test. These methodological differences
may explain why the agreement levels for these items
was somewhat lower than for other items, but also
highlights how these tests focus on different elements
of attention and how these (subtle) differences can im-
pact assessment of patients with delirium.
We have generated conversion rules from MDAS to
DRS–R98 scores and vice versa. The rules were de-
rived from initial assessments of a palliative
care population and were then tested on data from
the second assessment of these same patients three
days later (Meagher et al., 2011). The generated
scores were not significantly different from the actual
scores. The consistency of assessment methods and
raters almost certainly contributed to the high level
of agreement, and, this being said, further studies
in other populations are needed, but this initial study
suggests a promising level of accuracy that can facili-
tate comparisons of studies using different methods
of assessing delirium.
Diagnostic cutoff scores for delirium diagnosis
using the DRS–R98 and MDAS have been identified
that vary according to the population studied (Breit-
bart et al., 1997; Trzepacz et al., 2001; Kazmierski
et al., 2008; Shyamsundar et al., 2009). In our study,
we have not attempted to identify any particular cut-
offs. Some previous studies related to a conversion
rule suggested that, where high diagnostic sensi-
tivity was required, cutoff scores of 12 and 9 could ap-
ply for the DRS–R98 and MDAS, respectively, while
for greater specificity, scores of 15 and 12 could be ap-
plied (Trzepacz et al., 2010).
Future work can explore the value of identifying
specific ranges that equate with mild versus severe de-
lirium, including their relevance to predicting treat-
ment responsiveness and overall prognosis. While
these scales can capture the phenomenological inten-
sity of delirium, evidence that the hypoactive subtype
of delirium is associated with a poorer prognosis (and
possibly lower treatment response), despite relatively
lower scores for severity on these scales, highlight
the possible mismatch between phenomenological in-
tensity and prognostic severity (Kiely et al., 2007; Ko-
bayashi et al., 1992; Liptzin & Levkoff, 1992; Meagher
et al., 2008; Olofsson et al., 1996; Meagher et al., 2011).
Similarly, the issue of relative weighting of various
delirium symptoms/scale items also warrants con-
sideration. Both the MDAS and DRS–R98 allow for
detailed and systematic assessment of the broad phe-
nomenological profile of delirium, but both weight all
items equally (on a scale from 0 to 3). Where the prin-
cipal requirement is for accurate diagnosis of delir-
ium, it may be more prudent to focus on symptoms
that are especially diagnostically important, such
as inattention and disorganized thinking, which re-
flect two of the three core domains of delirium (Mat-
too et al., 2012; Franco et al., 2012). To this end,
inclusion of two items that rate inattention may be
a relative advantage of the MDAS, but, interestingly,
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the diagnostic cutoff scores for the DRS–R98 are
much more consistently identified. Where the princi-
pal aim is to predict prognosis, it may be better to em-
phasize features that are more closely linked to
outcome, such as motor profile combined with such
other parameters as comorbid dementia and/or pres-
ence of organ failure as a cause of delirium (Leonard
et al., 2008). It may be the case that different scales
may be better for assessment of the different clinical
(motor) subtypes of delirium and/or that a scale
which provides better coverage of relatively hypoac-
tive features of delirium needs to be developed.
LIMITATIONS
In the evaluation data (second assessment), the rat-
ings were provided by professionals with the same ex-
pertise, and the errors were perhaps minimal and in
the same direction. This conceivably influenced the
high agreement between the actual scale and the
converted one. It is essential that this conversion
rule apply to other areas of expertise as well. This
needs to be tested with different data and possibly
from different settings to generalize the conversion
rule. Ideally, a new prospective study will be designed
for this purpose. Our present study is a first attempt
at finding a rule that can convert different delirium
rating scales, and the data we obtained indicate
that our results are most promising.
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